Bjerrum Lars, Andersen Morten, Petersen Gert, Kragstrup Jakob
Research Unit of General Practice, University of Southern Denmark, Odense.
Scand J Prim Health Care. 2003 Sep;21(3):153-8. doi: 10.1080/02813430310001806.
To analyse the prevalence of potential drug interactions, and to identify patients particularly prone to drug interaction.
Database study (Odense University Pharmacoepidemiologic Database).
Individuals exposed to polypharmacy in 1999 were examined for potential drug interactions.
Inhabitants of the County of Funen (n = 471 732).
Prevalence of potential drug interactions.
One-third of the population were exposed to polypharmacy and among these 15% were exposed to drugs carrying a risk of harmful interaction. Among the elderly with polypharmacy, 25% aged 60-79 years and 36% over 80 years received drugs carrying the risk of interaction. Among individuals exposed to potential drug interaction, 62% were exposed only to one drug interaction and 38% to two or more different drug interactions. The drugs accounting for the highest number of potential interactions were diuretics, NSAIDs, ACE-inhibitors, digoxin, oral antidiabetics, calcium channel blockers, anticoagulants and beta-blockers. When focusing only on major drug interactions, potassium-sparing diuretics and oral anticoagulants were the most frequently involved drugs.
Elderly patients exposed to polypharmacy should be kept under intensified monitoring as they are at increased risk of clinically significant drug interactions.
分析潜在药物相互作用的发生率,并确定特别容易发生药物相互作用的患者。
数据库研究(奥登塞大学药物流行病学数据库)。
对1999年使用多种药物的个体进行潜在药物相互作用检查。
菲英岛居民(n = 471732)。
潜在药物相互作用的发生率。
三分之一的人群使用多种药物,其中15%的人使用了有有害相互作用风险的药物。在使用多种药物的老年人中,60至79岁的人群中有25%、80岁以上的人群中有36%使用了有相互作用风险的药物。在暴露于潜在药物相互作用的个体中,62%仅暴露于一种药物相互作用,38%暴露于两种或更多不同的药物相互作用。导致潜在相互作用数量最多的药物是利尿剂、非甾体抗炎药、血管紧张素转换酶抑制剂、地高辛、口服降糖药、钙通道阻滞剂、抗凝剂和β受体阻滞剂。仅关注主要药物相互作用时,保钾利尿剂和口服抗凝剂是最常涉及的药物。
使用多种药物的老年患者应加强监测,因为他们发生具有临床意义的药物相互作用的风险增加。